Amazon Faces Class Action Lawsuit Over Non-FDA Approved Supplement Labels

Published:

  • Corporate Lawsuits
amazon supplements header

Amazon is facing a class action lawsuit for selling supplements with misleading health claims and no FDA disclaimer. Consumers may be eligible for compensation.

Last Updated:

comments
share

Amazon, one of the largest e-commerce platforms in the world, is now under legal fire for its role in distributing dietary supplements that allegedly failed to comply with federal labeling laws.
 

A proposed class action lawsuit accuses Amazon of marketing and selling dietary supplements with misleading health claims, without including the required FDA disclaimer. According to the plaintiffs, this omission may have led consumers to wrongly believe the products were reviewed or approved by the U.S. Food and Drug Administration (FDA) when they were not.
 

The case is being heard in the U.S. District Court for the Western District of Washington and recently moved forward after a judge denied Amazon’s motion to dismiss.
 

If successful, this lawsuit could not only provide compensation for affected consumers but also reshape standards for online supplement sales across the country.
 

The Heart of the Case: Misleading Health Claims and FDA Violations

At the core of the lawsuit is the claim that Amazon knowingly allowed the sale of dietary supplements featuring structure-function health claims—statements like “supports heart health” or “boosts immunity”—without providing the legally mandated FDA disclaimer.
 

According to federal regulations, such disclaimers must state: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”
 

Without it, consumers may have believed that these supplements were medically approved or guaranteed to deliver specific health benefits, which could influence purchasing decisions.
 

The plaintiffs argue that Amazon, as both a seller and a platform, bears responsibility for misleading buyers and violating federal consumer protection laws.
 

What’s the Current Status of the Case?

The lawsuit is still in its early stages, but it’s gaining traction. In a major development, the judge denied Amazon’s attempt to dismiss the case, meaning the claims will proceed to the next phase of litigation.
 

This next stage, class certification, will determine whether the case can represent a larger group of consumers. If the class is certified, it will outline which products and purchases qualify and could lead to monetary relief for those affected.
 


 

A Wake-Up Call for Supplement Transparency

This case raises serious questions about accountability in the supplement industry and the responsibilities of major online retailers. As consumers increasingly turn to Amazon for health products, they expect transparency and regulatory compliance, not vague claims or missing disclaimers.
 

The outcome of this class action could influence how dietary supplements are labeled, marketed, and sold across the U.S., especially when it comes to platforms that serve millions of buyers.


For now, it’s a legal warning to sellers: misleading health claims and ignored regulations may lead to court.
 

Where the Class Action Goes From Here

Unless dismissed or settled, the Amazon supplement class action will move into the class certification phase, followed by discovery, hearings, and possibly a trial. If successful, it could open the door for a nationwide claims process and reshape the standards for online supplement marketing.
 

For affected consumers, it’s not just about the money but about holding a powerful company accountable for playing loose with federal regulations.
 

Who Is Eligible?

Eligibility for the Amazon supplement class action is still being defined, but the general criteria include:

  • You purchased dietary supplements through Amazon.
  • The product included structure-function health claims (e.g., “supports heart health”).
  • The label did not include the required FDA disclaimer.


If the court certifies the class, a full list of products and qualifying purchases will be released, giving consumers a clearer picture of who is affected.
 

What Could Consumers Receive?

As of now, there is no confirmed settlement or payout. However, if the class is certified and the plaintiffs prevail or reach a settlement, consumers who purchased misleadingly labeled supplements could be eligible for:

  • Refunds for the full or partial cost of the products
  • Compensation for damages resulting from reliance on misleading health claims
  • Potential injunctive relief to stop Amazon from selling such products in the future
     

The outcome of this case could set a precedent for supplement labeling and online retail accountability.
 

Why This Case Matters

This lawsuit is about more than just labels. It’s about trust. Consumers rely on accurate, transparent information when buying health-related products. When major retailers like Amazon skip crucial disclaimers, it puts consumer safety and informed decision-making at risk.
 

As supplements continue to flood the e-commerce market, cases like this one highlight the need for clear regulation, responsible selling, and better consumer protection.

Frequently Asked Questions (FAQ)

Amazon is being sued for selling dietary supplements that include health-related claims without the FDA-required disclaimer. Plaintiffs argue that this misled consumers into believing the products were FDA-approved.

Any supplements sold on Amazon that made structure-function health claims (e.g., “supports heart health”) without an FDA disclaimer could be included.

Follow updates on OnlyClassActions blog page or sign up for alerts to know when (and if) a claim process opens.

That is unclear. While the lawsuit doesn’t call for a product ban, it may result in stricter labeling requirements on Amazon going forward.

Add Comment